Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies?

Nature Reviews Immunology volume 10, pages 299–300 (2010)Cite this article

Subjects

Abstract

Patients treated with monoclonal antibodies directed against immunological molecules may be viewed as being similar to patients with primary immunodeficiency (PID) of the corresponding antibody target, with regards to infectious risk. László Maródi and Jean-Laurent Casanova propose that the natural history of PIDs might indicate which infectious diseases should be monitored in patients receiving therapeutic antibodies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wallis, R. S. Curr. Opin. Infect. Dis. 22, 403–409 (2009).

    Article  CAS  Google Scholar 

  2. Martin-Mola, E. & Balsa, A. Rheum. Dis. Clin. N. Am. 35, 183–199 (2009).

    Article  Google Scholar 

  3. Desai, S. B. & Furst, D. E. Best Pract. Res. Clin. Rheumatol. 20, 757–790 (2006).

    Article  CAS  Google Scholar 

  4. Carson, K. R. et al. N. Engl. J. Med. 361, 816–824 (2009).

    Google Scholar 

  5. Quartier, P. et al. Clin. Infect. Dis. 36, e47–e49 (2003).

    Article  Google Scholar 

  6. Aksoy, S. et al. Leuk. Lymphoma 50, 357–365 (2009).

    Article  CAS  Google Scholar 

  7. Casanova, J.-L. & Abel, L. Science 317, 617–619 (2007).

    Article  CAS  Google Scholar 

  8. Maródi, L. & Notarangelo, L. D. Nature Rev. Immunol. 11, 851–861 (2007).

    Article  Google Scholar 

  9. Suzuki, T. et al. J. Exp. Med. 205, 2703–2710 (2008).

    Article  Google Scholar 

  10. Martinez-Moczygemba, M. et al. J. Exp. Med. 205, 2711–2716 (2008).

    Article  CAS  Google Scholar 

  11. Patel, S. Y. et al. J. Immunol. 175, 4769–4776 (2005).

    Article  CAS  Google Scholar 

  12. Kampmann, B. et al. J. Clin. Invest. 115, 2480–2488 (2005).

    Article  CAS  Google Scholar 

  13. Ram, R. et al. Leuk. Lymphoma 50, 1083–1095 (2009).

    Article  CAS  Google Scholar 

  14. Kimby, E. Cancer Treat. Rev. 31, 456–473 (2005).

    Article  CAS  Google Scholar 

  15. Kanbayashi, Y. et al. Eur. J. Haematol. 82, 26–30 (2009).

    Article  CAS  Google Scholar 

  16. Kiani-Alikhan, S. et al. Br. J. Haematol. 146, 333–335 (2009).

    Article  Google Scholar 

  17. Padate, B. P. & Keidan, J. Clin. Lab. Haematol. 28, 69–71 (2006).

    Article  CAS  Google Scholar 

  18. Carrasco, R. et al. Paediatr. Drugs 6, 137–146 (2004).

    Article  Google Scholar 

  19. Bustamante, J. et al. Curr. Opin. Immunol. 20, 39–48 (2008).

    Article  CAS  Google Scholar 

  20. Zhang, S. Y. et al. Immunol. Rev. 226, 29–40 (2008).

    Article  CAS  Google Scholar 

  21. Picard, C. et al. The clinical features and outcome of IRAK-4 and MyD88 deficiencies. Medicine (in the press).

  22. Major, E. O. N. Engl. J. Med. 361, 1041–1043 (2009).

    Article  CAS  Google Scholar 

  23. Maródi, L. & Casanova, J.-L. Lancet 373, 2179–2181 (2009).

    Article  Google Scholar 

  24. Tóth, B. et al. Mol. Immunol. 46, 2140–2146 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. László Maródi is at the Department of Infectious and Pediatric Immunology, University of Debrecen Medical and Health Science Center, Debrecen, Hungary.,

    László Maródi

  2. Jean-Laurent Casanova is at the Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University Hospital, The Rockefeller University, New York, New York, USA, and Necker Branch, Paris Descartes University, Necker Medical School, Paris, France. lmarodi@dote.hu; jean-laurent.casanova@rockefeller.edu,

    Jean-Laurent Casanova

  3. jean-laurent.casanova@rockefeller.edu,

    Jean-Laurent Casanova

Authors
  1. László Maródi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Laurent Casanova
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maródi, L., Casanova, JL. Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies?. Nat Rev Immunol 10, 299–300 (2010). https://doi.org/10.1038/nri2764

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nri2764

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing